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NOEHere we report an NMR study on the substrate interaction modes of GroEL using amyloid b (Ab) as a
model ligand. We found that GroEL could suppress Ab(1–40) amyloid formation by interacting with
its two hydrophobic segments Leu17-Ala21 and Ala30-Val36, which involve key residues in ﬁbril for-
mation. The binding site of Ab(1–40) was mapped on a pair of a-helices located in the GroEL apical
domain. These results provide insights into chaperonin recognition of amyloidogenic proteins of
pathological interest.
Structured summary of protein interactions:
Ab(1–40) and Ab(1–40) bind by ﬂuorescence technology (View interaction)
GroEL and Ab(1–40) bind by nuclear magnetic resonance (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Molecular chaperones play vital roles in various cellular pro-
cesses by assisting the correct folding and assembly of proteins un-
der normal physiological and stress conditions [1]. The chaperonin
GroEL from Escherichia coli has been one of the most extensively
studied molecular chaperones [2,3]. GroEL comprises 14 identical
subunits with a molecular mass of 57 kDa. These are arranged in
two homoheptameric rings that are stacked back-to-back, thereby
forming a large cylindrical complex with a central cavity of approx-
imately 45 Å in diameter [4].Each subunit consists of three domains: apical, intermediate,
and equatorial [4]. The apical domains form the entrance to the
central cavity and provide the binding sites for various substrate
proteins as well as co-chaperonin GroES. The equatorial domain
has an ATP-binding site and mediates inter-subunit contacts with-
in and between the rings. The intermediate domain acts as a hinge
that connects the other two domains.
The interactions between GroEL and its substrates have been
characterized using various model proteins/peptides. A transferred
NOE (trNOE) analysis indicated that a rhodanese peptide adopted
an a-helical conformation upon binding to a monomeric fragment
encompassing the apical domain of GroEL (designated a minichap-
erone) [5]. A crystallographic study demonstrated that a phage dis-
play-selected peptide exhibited a b-hairpin structure that occupied
the same binding site of a minichaperone (helices H and I of the
apical domain) [6]. Hydrogen–deuterium exchange studies sug-
gested that substrates lacked well-deﬁned tertiary structure pack-
ing although the degrees of structural disorder were different for
different proteins [7–10]. Direct NMR observations indicated that
GroEL-bound substrate proteins were largely unstructured and
highly dynamic [11,12]. However, arguments against the chaper-
oning mechanisms of GroEL are still controversial [13].
In pathological contexts, molecular chaperones presumably
contribute to inhibiting protein-folding diseases, such as
0 
20
40
60
0 10 20 30 40 50 60
Th
T
flu
or
es
ce
nc
e 
in
te
ns
ity
 (A
.U
.)
Time (hour)
Fig. 1. Ab(1–40) amyloid ﬁbril formation is inhibited by GroEL. Ab(1–40) solutions
were incubated at peptide concentrations of 20 lM (circles) and 40 lM (squares) in
the presence (open) or absence (ﬁlled) of 20 lM GroEL. ThT ﬂuorescence intensity
was estimated by excluding background activity at 0 h. Each intensity value is the
mean ± S.D. of four values.
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Fig. 2. Ab(1–40) peptide interacts with GroEL through its hydrophobic segments, whic
labeled Ab(1–40) in the presence (black) and absence (red) of GroEL. (B) Plots of the inte
The primary structure of Ab(1–40) peptide is represented at the top of the plots. Aster
spectrum. Intensity ratio is the mean ± S.D. of three independent experiments.
1606 M. Yagi-Utsumi et al. / FEBS Letters 587 (2013) 1605–1609neurodegenerative disorders, by preventing the formation of toxic
protein aggregates and by actively removing these aggregates in an
ATP-dependent manner [14]. It was recently shown that the GroEL
minichaperone had an inhibitory effect on seed-dependent b2-
microglobulin amyloid formation [15] and GroEL was capable of
interacting with a-synuclein, the major component of the Lewy
bodies in Parkinson’s disease [16].
In light of these observations, we examined a possible interac-
tion between GroEL and amyloid b (Ab), an amyloidogenic peptide
responsible for Alzheimer’s disease [17,18]. Based on thioﬂavin T
(ThT) ﬂuorescence and NMR data, we found that GroEL interacts
with monomeric Ab(1–40), thereby inhibiting its amyloid
formation.
2. Materials and methods
2.1. Preparation of GroEL and minichaperone
GroEL was overexpressed in E. coli BL21 (DE3) cells that har-
bored pLysS and an appropriate expression plasmid. Cells were
grown in 2 YT medium containing 50 lg/ml of ampicillin at
37 C. To produce perdeuterated GroEL proteins, cells were grown
in M9 minimal medium containing 2H2O at 37 C. When A600 nm
reached 0.6, 1 mM isopropyl-b-D-thiogalactopyranoside was added7.5
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nsity ratios of the backbone amide peaks of Ab(1–40) upon interaction with GroEL.
isk indicates an amino acid residue that did not exhibit an observable peak in the
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Fig. 3. A pair of a-helices on minichaperone is involved in the interaction with Ab(1–40). (A) Chemical shift differences are shown at a molar ratio of 1:2 (minichaperone:
Ab(1–40)) according to the equation Dd ¼ ð0:04Dd2N þ Dd2HÞ1=2, where dN and dH represent the difference in nitrogen and proton chemical shifts, respectively. Secondary
structure of minichaperone are shown at the top of the plots; the a-helix is depicted by a cylinder (black) and b-strand by an arrow (white). Asterisk indicates an amino acid
residue that did not exhibit an observable peak in the spectrum while ‘‘P’’ represents a proline residue. (B) Chemical shift perturbations are mapped on the 3D-structure of
minichaperone (PDB code: 1JON). Colors indicate the value of Dd upon addition of Ab(1–40) peptide as follows: >0.02 ppm (red), 0.015–0.02 ppm (sermon pink), and
<0.015 ppm (gray).
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37 C. Recombinant GroEL puriﬁcation was performed as described
previously [19]. A bacterially expressed minichaperone, corre-
sponding to residues 193–335 of GroEL, was uniformly enriched
with 15N in M9 minimal medium containing 15NH4Cl and puriﬁed
according to the literature [5].
2.2. Preparation of Ab(1–40)
The expression and puriﬁcation of recombinant Ab(1–40) were
performed as described previously [20]. To produce isotopically la-
beled Ab(1–40), cells were grown in M9 minimal media containing
[ring-D5]phenylalanine (200 mg/l), [15N]NH4Cl (1 g/l) and/or
[U-13C6] glucose (2 g/l). Ab(1–40) was dissolved at a concentration
of approximately 2 mM in a 0.1% (v/v) ammonia solution and then
collected and stored in aliquots at 80 C until use.
2.3. ThT assay
Ab(1–40) was dissolved at concentrations of 20 and 40 lM in
10 mM potassium phosphate buffer (pH 7.2) in the absence or
presence of 20 lM GroEL, followed by incubation at 37 C. A
5 lM ThT (Sigma) solution (990 ll) in 50 mM glycine/NaOH buffer
(pH 8.5) was added to a 10 ll aliquot of each sample. Fluorescence
intensity was measured immediately after mixing at excitation andemission wavelengths of 446 and 490 nm, respectively, using a
spectroﬂuorophotometer (Hitachi F-4500) at room temperature.
2.4. NMR measurements
NMR spectral measurements were made on a Bruker DMX-500
spectrometer equipped with a cryogenic probe and a JEOL ECA-
600 spectrometer. For 1H–15N heteronuclear single-quantum corre-
lation (HSQC) measurements of Ab, isotopically labeled Ab(1–40)
was dissolved at a concentration of 20 lM in 10 mM potassium
phosphate buffer (pH 7.2) containing 10% (v/v) 2H2O in the presence
or absence of 20 lMGroEL. HSQCmeasurementsweremade at 5 C.
1H–15N HSQC measurements of isotopically labeled minichaperone
weremade at a protein concentration of 0.2 mM in 50 mMTris-d11–
HCl buffer (pH 6.9) containing 150 mM NaCl and 10% (v/v) 2H2O in
the presence or absence of 0.4 mM unlabeled Ab(1–40) at 30 C. For
trNOEmeasurements, Ab(1–40) was dissolved at a concentration of
300 lM in 10 mM potassium phosphate buffer (pH 7.2) containing
99% (v/v) 2H2O in the presence or absence of 20 lM GroEL. Proton
signals of the free Ab(1–40) peptide were assigned by conventional
homonuclear methods based on 2D-TOCSY and NOESY experi-
ments. 2D-NOESY spectra with mixing times of 50, 100, 200, 400,
800, and 1000 ms were measured at 4 C. For trNOE assignments,
2D-NOESY experiments with a mixing time of 400 ms were
recorded using a spectral width of 6000 Hz and 256 scans
1608 M. Yagi-Utsumi et al. / FEBS Letters 587 (2013) 1605–1609per increment. NMR spectra were processed and analyzed with the
programs nmrPipe [21] and Sparky [22].3. Results and discussion
3.1. GroEL suppresses Ab(1–40) aggregation
We ﬁrst examined a possible effect of GroEL on Ab(1–40) aggre-
gation using a ThT assay. As shown in Fig. 1, ThT ﬂuorescence was
signiﬁcantly enhanced during incubation with Ab(1–40) at 37 C,
indicating its formation of amyloids. The enhanced ﬂuorescence
was nearly completely suppressed when co-incubated with equi-
molar GroEL. These data clearly demonstrated that GroEL could
interact with Ab(1–40) and thereby inhibited its aggregation. Thus,
we used Ab(1–40) as a model ligand to investigate the substrate-
binding mode of GroEL by NMR spectroscopy.
3.2. GroEL interacts with discontinuous segments of Ab(1–40)
For detailed NMR analyses, we prepared isotopically labeled
Ab(1–40) using a bacterial expression system. Fig. 2A shows the
1H–15N HSQC spectra of 15N-labeled Ab(1–40) in the absence and
presence of GroEL at an equimolar concentration. GroEL induced
signiﬁcant attenuation of peak intensities in two separate hydro-
phobic segments in Ab(1–40): Leu17-Ala21 and Ala30-Val36
(Fig. 2B). Intriguingly, these two segments are involved in
b-strands when Ab(1–40) forms an amyloid ﬁbril [23] and adopt
a-helical structures when Ab(1–40) is accommodated on a cluster
of GM1 gangliosides, which is supposed to provide a platform to
facilitate Ab aggregation [24,25].
For further characterization of the interaction, we attempted to
observe intermolecular transferred NOE between Ab(1–40) and
GroEL. In the spectra with mixing times ranging from 50 to
1000 ms, while no local NOE peak was detected characterizing an
a-helical secondary structure, an unambiguous intermolecular
NOE connectivity was identiﬁed between Phe19 He of Ab(1–40)
and a GroEL methyl group (Supplementary Fig. S1). It has been re-
ported that the Phe19 side chain signiﬁcantly contribute to ﬁbril
formation of Ab(1–40) by stabilizing the hydrophobic core of the
ﬁbril [26].
3.3. Ab(1–40) binding site was mapped on minichaperone
To identify the Ab(1–40) binding site on GroEL by NMR analysis,
we employed a minichaperone corresponding to residues 193–335
of GroEL, of which spectral assignment was established [5]. Fig. 3A
and Supplementary Fig. S2 compare 1H–15N HSQC spectra of the
minichaperone in the presence and absence of Ab(1–40). Signiﬁ-
cant chemical shift perturbations [ð0:04Dd2N þDd2HÞ1=2 > 0:02 ppm,
where dN and dH represent the difference in nitrogen and proton
chemical shifts, respectively] were observed for Ala241, Leu262,
Ile270, and Val271. Most of these amino acid residues are located
in helix H and helix I, which provide binding site for the model sub-
strates of GroEL as well as the mobile loop of GroES [5,6,27,28]. The
binding of the helix pair to the ligands were characterized primar-
ily by hydrophobic interactions. In the crystal structure, a phenyl-
alanine side chain of the phage display-selected peptide was
accommodated in a hydrophobic pocket formed by the two helices
H and I with extensive contacts with Leu234, Leu237, Thr261, and
Asn265 [6]. By inspecting these data, we suggest that the apical do-
mains of GroEL capture the hydrophobic residues of Ab(1–40) and
thereby suppresses its amyloid formation.
It has been supposed that molecular chaperones actively con-
tribute to the prevention of toxic aggregate formation of various
amyloidgenic proteins relevant to neurodegenerative disorders[14]. Our ﬁndings offer insights into molecular mechanisms under-
lying the chaperonin recognition of amyloidogenic proteins of
pathological interest.
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